Karin de Visser is senior group leader at the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via PubMed.
| Category | 🧬 Medicine & Biology |
| Published | Nov 18, 2025 |
| Journal | Cell reports. Medicine |
| Authors | de Visser Karin |
| DOI | 10.1016/j.xcrm.2025.102457 |
| Source | PubMed |